KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Intangibles (2016 - 2025)

Opko Health (OPK) has disclosed Intangibles for 16 consecutive years, with $516.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Intangibles fell 16.27% year-over-year to $516.3 million, compared with a TTM value of $516.3 million through Dec 2025, down 16.27%, and an annual FY2025 reading of $516.3 million, down 16.27% over the prior year.
  • Intangibles was $516.3 million for Q4 2025 at Opko Health, down from $730.4 million in the prior quarter.
  • Across five years, Intangibles topped out at $1.0 billion in Q4 2022 and bottomed at $321.7 million in Q4 2021.
  • Average Intangibles over 5 years is $682.7 million, with a median of $685.9 million recorded in 2024.
  • The sharpest move saw Intangibles skyrocketed 210.87% in 2022, then tumbled 38.22% in 2025.
  • Year by year, Intangibles stood at $321.7 million in 2021, then surged by 210.87% to $1.0 billion in 2022, then fell by 6.47% to $935.3 million in 2023, then tumbled by 34.07% to $616.6 million in 2024, then fell by 16.27% to $516.3 million in 2025.
  • Business Quant data shows Intangibles for OPK at $516.3 million in Q4 2025, $730.4 million in Q3 2025, and $556.0 million in Q2 2025.